Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2013

Aug 27, 2013

34395_dirs_2013-08-27_759b90a3-60fb-4550-8ceb-b954af7d1715.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2012-12-31

Reporting Person: Innes Guy Archibald (Director)

Holdings (Non-Derivative)

Security Shares Ownership
COMMON STOCK 868926 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
WARRNAT $0.5 2016-03-24 COMMON STOCK (100000) 100000 Direct
OPTION $3 2015-05-25 COMMON STOCK (5000) 5000 Direct
OPTION $3 2015-11-25 COMMON STOCK (5000) 5000 Direct
OPTION $4 2016-05-25 COMMON STOCK (5000) 5000 Direct
OPTION $4 2016-11-25 COMMON STOCK (5000) 5000 Direct
OPTION $5 2017-05-25 COMMON STOCK (5000) 5000 Direct
OPTION $5 2017-11-25 COMMON STOCK (5000) 5000 Direct
WARRANT $2.6 2016-05-10 COMMON STOCK (74821) 74821 Direct

Footnotes

F1: On October 6, 2011, Guy Archibald Innes was appointed as a member of the Board of Directors of the Company.

F2: $1.75 Unit Price paid for 149,639 shares of common stock reported in Table 1, which included a Warrant to purchase 74,821 shares of common stock at $2.60 for four years.